ReviewTight Junctions as Targets and Effectors of Mucosal Immune Homeostasis
Keywords
Abbreviations used in this paper
Cited by (0)
Author contributions Li Zuo: conceptualization, equal; funding acquisition, supporting; writing original draft, lead; writing review and editing, equal. Wei-Ting Kuo: conceptualization, equal; writing original draft, equal; writing review and editing, equal. Jerrold R. Turner: conceptualization, lead; funding acquisition, lead; writing original draft, lead.
Conflicts of interest This author discloses the following: Jerrold R. Turner is a co-founder of Thelium Therapeutics, Inc. The remaining authors disclose no conflicts.
Funding This work was supported by NIH grants R01DK61931 (JRT), R01DK68271 (JRT), and R24DK099803 (JRT); the Harvard Digestive Disease Center (P30DK034854); the Department of Defense CDMRP PR181271 (JRT); and by National Natural Science Foundation of China grant 81800464 (LZ).
- ∗
These authors contributed equally.